Can Peer Review Be Improved?

The December 15, 1986 issue of The Scientist contained an excerpt from Drummond Rennie's piece on peer review in JAMA (vol. 256, pp. 2391-2392, November 7, 1986), which included the statement "The function of peer review, then, may be to help decide not whether but where papers are published and to improve the quality of those that are accepted." This function is now performed by peer reviewers of scientific journals and granting agencies. Peer review as practiced now, however, poses a serious o

Written byMoshe Wolman
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

This function is now performed by peer reviewers of scientific journals and granting agencies. Peer review as practiced now, however, poses a serious obstacle to the advance of science.

The journal or granting agency sends the article or research proposal to "experts in the field." These are scientists who earlier may have revolted against prevalent dogma and generally accepted opinion. They became recognized as experts once their own notions (and those of their peers) became recognized as the generally accepted truth. As peer reviewers, these scientists are likely to reject notions that contradict accepted dogmas and statements of others who do not realize that "it is common knowledge that "The situation might be more perilous in granting agencies, where a new idea that can be validated only by a time-consuming series of experiments or observations is likely to be labeled by experts as a nonproductive wild goose chase.

I would ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies